Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

February 12, 2026 updated by: International Spine Study Group Foundation
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Study Overview

Detailed Description

Specific Aims:

  • Evaluate the safety and performance of posterior spinal fusion constructs supplemented with posterior spinolaminar fixation using the VersaTie System compared to posterior fixation constructs without VersaTie System supplementation in adult patients undergoing long posterior spinal fusion by evaluating intraoperative and postoperative complications, clinical and radiographic outcomes, patient-reported outcomes (PROs) and need for revision surgery.
  • Evaluate surgical treatment outcomes and identify best practice guidelines for complex adult spinal deformity (ASD) patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for and revision surgery.
  • Develop and validate a standardized, universal complications classification system for spine surgery
  • Evaluate perioperative blood management approaches, transfusion requirements, including variance in thresholds for blood transfusion and associated complications for adult spinal deformity surgery
  • Assess impact of opioid use and pain management on patient cost, complications and outcomes
  • Evaluate optimal opioid and analgesic usage and protocols for standard work development
  • Evaluate clinical outcomes utilizing legacy patient reported outcome measures (PROMs) including modified Oswestry Disability Index (mODI), Scoliosis Research Society Questionnaire 22r (SRS-22r), Veterans RAND-12 (VR-12), and numeric pain rating scale (NRS) and compare the results of these legacy PROMs to outcomes scores as measured by the NIH Patient Reported Outcomes Measurement Information System (PROMIS) - PROMIS Anxiety, Depression, Pain Interference, Physical Function, and Social Satisfaction. Secondary aims for PROM research for this study include

    1. Validation of the PROMIS tool for ASD
    2. Establish a core set of PROMs for best practice guidelines for ASD
    3. Evaluate patient reported outcome variance for ASD according to SRS-Schwab spine deformity type including variance in baseline PROM domains impacted and variance in improvement in PROM domains
    4. Evaluate ASD outcomes compared to population norms and investigate/develop appropriate measures of clinically significant improvement
  • Evaluate clinical outcomes stratifying by patient chronological and physiological age
  • Evaluate measures to quantify patient physiological age including patient frailty for ASD and validate a frailty measurement system for ASD
  • Evaluate the role of functional tests in patient's baseline frailty assessment including hand manometer and Edmonton Frail Scale. See appendix, pages 17 & 18 for details.
  • Evaluate the contribution of patient frailty to patient outcomes, complications, cost of care, disability, and complications
  • Evaluate if patient frailty is a static measure or if frailty is a dynamic measure that can be improved through "pre-habilitation" and if the according associations with reductions in frailty correlate with reductions of cost, complications, and improvement in outcomes
  • Evaluate cost variance for ASD surgery according to patient, institution, and geographical region and evaluate the cost effectiveness of surgical intervention for ASD
  • Evaluate incidence of and risk factors for mental health (MH) compromise among ASD patients and establish best practice guidelines for assessing MH for ASD patients
  • Evaluate the association of MH with surgical complications, outcomes, hospital length of stay and cost for ASD surgery
  • Evaluate the association of social health surgical complications, outcomes, hospital length of stay and cost for ASD surgery and risk factors for routine (home) discharge vs. skilled nursing facility (SNF)/rehabilitation facility
  • Broaden the evaluation of the surgically treated ASD patient to maximize evaluation of the entirety of the episode of care to include steps that can be taken prior to surgery including "prehabilitation," pain management, and MH care to improve treatment outcomes, reduce cost, reduce hospital length of stay, reduce non-routing discharge and reduce early and late complications
  • Establish a core set of standard work guidelines to clinically and radiographically evaluate and treat ASD patients and evaluate the utility of standard work to improve outcomes for ASD and formulate best practice guidelines for surgical treatment of ASD
  • Develop predictive analytic algorithms to risk stratify for best/worst outcomes, complications, sentinel events, and economic loss for ASD surgery
  • Evaluate the prevalence and incidence of sacroiliac pain before/after complex adult spinal deformity surgery.

Study Type

Observational

Enrollment (Estimated)

225

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85013
    • California
      • La Jolla, California, United States, 92037
        • Recruiting
        • Shiley Center for Orthopaedic Research and Education at Scripps Clinic
        • Principal Investigator:
          • Gregory Mundis, MD
        • Sub-Investigator:
          • Robert Eastlack, MD
        • Contact:
      • San Francisco, California, United States, 94143
        • Withdrawn
        • University of California - San Francisco
    • Colorado
      • Denver, Colorado, United States, 80218
        • Recruiting
        • Presbyterian/St. Luke's Medical Center
        • Contact:
        • Principal Investigator:
          • Shay Bess
    • Louisiana
      • Shreveport, Louisiana, United States, 71101
    • New York
      • Buffalo, New York, United States, 14260-1660
        • Recruiting
        • University at Buffalo, Department of Neurosurgery
        • Principal Investigator:
          • Jeffrey Mullin, MD
        • Contact:
      • New York, New York, United States, 10003
        • Recruiting
        • New York University, Department of Orthopedic Surgery
        • Contact:
        • Principal Investigator:
          • Themistocles Protopsaltis, MD
    • North Carolina
      • Durham, North Carolina, United States, 27708
        • Not yet recruiting
        • Duke University Health System
        • Contact:
        • Principal Investigator:
          • Christopher I Shaffrey, MD
    • Virginia
      • Charlottesville, Virginia, United States, 22908
        • Recruiting
        • University of Virginia
        • Principal Investigator:
          • Justin Smith, MD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Multicenter, prospective, observational, study evaluating the safety and performance of the VersaTie System by comparing adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System

Description

Inclusion Criteria:

  1. >18 years of age at the time of treatment
  2. EOS full body or standing 36" AP & Lateral images of entire spine
  3. Posterior spine fusion with pedicle screw fixation construct of 5 or more levels
  4. Pedicle screw fixation to be supplemented proximally with NuVasive VersaTie system
  5. Upper instrumented vertebra (UIV) terminating at a newly instrumented level
  6. Lowest instrumented vertebra (LIV) sacrum/pelvis
  7. Surgery scheduled to take place in the next 6 months

Exclusion Criteria:

  1. Active spine tumor or infection
  2. Deformity due to acute trauma
  3. Prisoners
  4. Women who are pregnant
  5. Patient is unwilling or unable to complete questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
VersaTie
Adult patients receiving minimum 5 level posterior spinal fusion with pedicle screw fixation supplemented at the proximal aspect of the construct with the VersaTie System.
Other Names:
  • VersaTie System

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scoliosis Research Society (SRS) 22r
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Scoliosis specific patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Oswestry
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Spine specific patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Veterans RAND 12 Item Health Survey (VR-12)
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Anxiety
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Depression
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Pain Interference
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Physical Function
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Satisfaction
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient-Reported Outcome Measurement Information System (PROMIS) - Social Role
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Patient reported outcome
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Visual Analog Scale - Back Pain
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Self-reported back pain on scale of 0 (No pain) to 10 (severe pain)
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Visual Analog Scale - Leg Pain
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Self-reported leg pain on scale of 0 (No pain) to 10 (severe pain)
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edmonton Frail Scale
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Evaluate frailty on scale of 0 to 17 where higher scores mean more frail
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Canadian Study of Health and Aging (CSHA)
Time Frame: Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Frailty scale of 1 to 9; higher scores mean more frail
Change from Preop to 3 months and 1, 2, 5 & 10 year follow-up
Adverse Events
Time Frame: 3 months and 1, 2, 5 & 10 year post treatment

Occurrence of Adverse events meeting reporting criteria and their relationship to intervention throughout the study

[Time Frame: 3 months and 1, 2, 5 & 10 year post treatment]

3 months and 1, 2, 5 & 10 year post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Shay Bess, MD, Presbyterian/St Luke's Medical Center
  • Principal Investigator: Jeffrey Mullin, MD, University at Buffalo, Department of Neurosurgery
  • Principal Investigator: Christopher Shaffrey, MD, Duke University Medical Center, Section of Spine Surgery
  • Principal Investigator: Justin Smith, MD, University of Virginia Medical Center, Department of Neurosurgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 9, 2021

Primary Completion (Estimated)

December 31, 2031

Study Completion (Estimated)

December 31, 2034

Study Registration Dates

First Submitted

May 11, 2021

First Submitted That Met QC Criteria

May 11, 2021

First Posted (Actual)

May 17, 2021

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 12, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scoliosis

Clinical Trials on Index or revision spine surgery for complex adult spinal deformity

Subscribe